Back to search

Article

Restoration of β-globin expression with optimally designed lentiviral vector for β-thalassemia treatment in Chinese patients

2020-07-21

Abstract excerpt

β-thalassemia is one of the most prevalent genetic diseases worldwide. The current treatment for β–thalassemia is allogeneic hematopoietic stem cell transplantation (HSCT), which is limited due to lack of matched donors. Gene therapy has been developed as an alternative therapeutic option for transfusion-ependent β -thalassemia (TDT). However, successful gene therapy for β -thalassemia patients in China has not...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e12c7a62-9931-5a3c-b6a0-51f875e0e530
DOI
10.1101/2020.07.18.209759
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Restoration of β-globin expression with optimally designed lentiviral vector for β-thalassemia treatment in Chinese patientsDOI 10.1101/2020.07.18.209759
Select a neighboring publication to make it the new centre.